About ViSalus
ViSalus is a Healthcare company based in Troy (United States) founded in 2005, and was acquired by Blyth in August 2008. Direct seller of nutritional supplements, energy drinks and weight management products. ViSalus has raised $6.41 million across 2 funding rounds from investors including Blyth. The company has 486 employees. The company was acqui-hired. Its focus areas include Life Sciences, Nutraceuticals Tech, Supplements and Multicategory. Its legal entity is VISALUS, INC. Its competitors include Carson Life, Mead johnson and Balchem; 1 of its 3 listed competitors has raised funding.
Company details
ViSalus is a direct seller of nutritional supplements, energy drinks and weight management products. It offers weight management products, including Vi-Trim, an appetite-suppressant drink mix; nutritional cookies; Vi-Shape, a meal replacement shake to promote weight loss through health flavor mix-in system; and Vi-Slim Metab-Awake tablets that are metabolism supporting tablets. It also provides various kits for the consumers such as Weight loss kit, lifestyle kit, fitness kit. The company was founded in 2005 and got acquired by Blyth Inc. in 2012. Bryant Park Capital served as financial advisor in connection with this transaction.
- Headquarters Troy, United States
- Employees 486
- Stage Acquired
- SectorsHealthcare
- Website visalus.com
- Social LinkedIn X Facebook
- Acquired by Blyth (Aug 2008)
- Legal Name Visalus, Inc.
Funding Insights of ViSalus
ViSalus has successfully raised a total of $6.41M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $6.41 million completed in May 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $6.41M
- Total Rounds 2
- Last Round Series A β $6.41M
- First Round $6.41M
(Feb 2016)
All 2 funding rounds of ViSalus with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2016 | $6.41M | Series A | β | β | β |
| Feb 2016 | $6.41M | Debt – Conventional | β | β | β |
1 investors in total: 1 institutional.
Investors in ViSalus
ViSalus has secured backing from 1 investor. Prominent investors backing the company include Blyth.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Limited information available | 1977 | blyth.com | Greenwich, United States |
Investor details for ViSalus
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of ViSalus
4 dated milestones of ViSalus across 11 years, from founding to its latest funding, stage changes and deals.
- Founded ViSalus is founded.
- Exit Acquired by Blyth.
- Funding First funding round of $6.4M.
- Funding Latest funding round, Series A, of $6.4M.
Competitors of ViSalus
ViSalus has 3 listed competitors in our database, 1 of them funded. They include Carson Life, Mead johnson and Balchem.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| carsonlife.com | 2014 | Miami, United States | $5.44M | Natural health and beauty products are manufactured in various categories. | ||
| meadjohnson.com | 1900 | Chicago, United States | 570 | Infant nutrition products are manufactured and marketed by Mead Johnson. | ||
| balchem.com | 1967 | New Hampton, United States | 2,293 | Nutraceutical ingredients are manufactured for human and animal nutrition products. |
Detailed competitors of ViSalus
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of ViSalus
Websites that share an audience with ViSalus (visalus.com).
Websites whose visitors overlap most with ViSalus. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
youngandraw.com | youngandraw.com | 100% | β | ||
lazymanandmoney.com | lazymanandmoney.com | 69% | #3,521,600 | β | |
myvi.net | myvi.net | 42% | β | ||
bodybyvi.com | bodybyvi.com | 41% | #1,791,158 | β |
Top companies in Nutraceutical & Food-as-Medicine Platforms
3 companies that operate in the same segment as ViSalus (Nutraceutical & Food-as-Medicine Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapies for metabolic health in chronic disease patients are provided. | 2014 | San Francisco, California, United States | USD 401.78 M | 910 | ||
Personalized gut health solutions are provided by ZOE. | 2017 | New Castle, Pennsylvania, United States | USD 15 M | |||
Machine learning-based bioinformatics solutions for health insights are provided. | 2016 | Los Alamos, New Mexico, United States | USD 301.57 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Visalus
Complete news archive for ViSalus
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ViSalus
ViSalus was founded in 2005 and raised its 1st funding round 11 years after it was founded.
ViSalus is headquartered in Troy, United States.
ViSalus is a funded company, having raised a total of $6.41M across 2 funding rounds to date. The company's 1st funding round was a Debt β Conventional of $6.41M, raised on Feb 2016.
ViSalus has 486 employees.
ViSalus is a direct seller of nutritional supplements, energy drinks and weight management products. It offers weight management products, including Vi-Trim, an appetite-suppressant drink mix; nutritional cookies; Vi-Shape, a meal replacement shake to promote weight loss through health flavor mix-in system; and Vi-Slim Metab-Awake tablets that are metabolism supporting tablets. It also provides various kits for the consumers such as Weight loss kit, lifestyle kit, fitness kit. The company was founded in 2005 and got acquired by Blyth Inc. in 2012. Bryant Park Capital served as financial advisor in connection with this transaction.
ViSalus's top competitors include Mead johnson, Balchem and Carson Life.
ViSalus has 1 investor. Key investors include Blyth.
ViSalus operates through Visalus, Inc..
Yes. ViSalus was acquired by Blyth in August 2008.

